Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New ODE Deputy Director Brings IT Focus To Premarket Device Initiatives

This article was originally published in The Gray Sheet

Executive Summary

Deputy Director for Technology & Review Policy Donna-Bea Tillman will head efforts to advance electronic device submissions development during her six-month detail at the CDRH Office of Device Evaluation

You may also be interested in...



Electronic Device Reviews, Staff Training On ODE’s To-Do List In FY 2005

CDRH's Office of Device Evaluation Director Donna-Bea Tillman, PhD, plans to initiate a dialogue with industry to gauge stakeholder interest in electronic review of premarket submissions

Electronic Device Reviews, Staff Training On ODE’s To-Do List In FY 2005

CDRH's Office of Device Evaluation Director Donna-Bea Tillman, PhD, plans to initiate a dialogue with industry to gauge stakeholder interest in electronic review of premarket submissions

CDRH Review Process Improvements Detailed In Report

OIVD will initiate a computer-based pilot of its "TURBO" 510(k) program in June, keeping the in vitro diagnostic device office on track to launch the optional program in December, according to FDA

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel